Foresters Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-97,811
Closed -$4.1M 52
2018
Q4
$4.1M Sell
97,811
-9,275
-9% -$385K 2.28% 7
2018
Q3
$5.75M Buy
107,086
+30,776
+40% +$1.18M 1.9% 12
2018
Q2
$3.46M Buy
76,310
+73,148
+2,313% +$2.5M 1.21% 20
2018
Q1
$101K Hold
3,162
0.07% 49
2017
Q4
$136K Sell
3,162
-12,648
-80% -$431K 0.05% 58
2017
Q3
$670K Hold
15,810
0.26% 54
2017
Q2
$654K Hold
15,810
0.27% 50
2017
Q1
$683K Buy
15,810
+1,054
+7% +$33.2K 0.32% 48
2016
Q4
$455K Sell
14,756
-131,223
-90% -$4.01M 0.26% 58
2016
Q3
$4.69M Buy
145,979
+211
+0.1% +$7.05K 2.41% 7
2016
Q2
$4.87M Buy
+145,768
New +$4.65M 2.53% 7

Other funds holding PFE

Foresters Asset Management's PFE Position: Q1 2019 in Review

Foresters Asset Management sold out of Pfizer (PFE) in Q1 2019, closing a stake of 97,811 shares — an estimated $4.1M sold.

Foresters Asset Management first reported a position in PFE in Q2 2016 and held it in 11 quarters. The position peaked at $5.75M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Foresters Asset Management reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Foresters Asset Management sold 97,811 Pfizer shares in Q1 2019, an estimated $4.1M.
  • Foresters Asset Management first reported a position in Pfizer in Q2 2016 and held it in 11 quarters.
  • Foresters Asset Management's Pfizer position peaked at $5.75M in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Foresters Asset Management's 13F filing for Q1 2019, filed 14 May 2019.